Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001415889-25-001312

Options or other derivatives

  • Chief Financial Officer acquired 525,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
DeLucia David Chief Financial Officer 2025-01-09 Grant or award · Stock Option (Right to Buy) +525,000 525,000 D: show line 1 in the form
Loading xslF345X05/form4-01102025_110123.xml…